BBOT
#3358
BridgeBio Oncology Therapeutics, Inc. - Common Stock
3.2 6 USD
-0.02%
Market Price
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
Faixa anual
Mudança diária
-1.51%
Mudança mensal
-33.60%
Mudança em 6 meses
-63.58%
Mudança anual
-71.53%
Fechamento anterior
3.3 1
Open
3.3 1
Mínimo
3.2 3
Máximo
3.3 7
Financials
2026
Current report, Q1 FY2026
Bridgebio Oncology Therapeutics, Inc. current report, Q1 FY2026
8-K
2025
Annual report, FY2025
Bridgebio Oncology Therapeutics, Inc. annual report, FY2025
10-K
Current report, Q4 FY2025
Bridgebio Oncology Therapeutics, Inc. current report, Q4 FY2025
8-K
Quarterly report, Q3 FY2025
Bridgebio Oncology Therapeutics, Inc. quarterly report, Q3 FY2025
10-Q
Current report, Q3 FY2025
Bridgebio Oncology Therapeutics, Inc. current report, Q3 FY2025
8-K
Current report, Q3 FY2025
Bridgebio Oncology Therapeutics, Inc. current report, Q3 FY2025
8-K
Current report, Q3 FY2025
Bridgebio Oncology Therapeutics, Inc. current report, Q3 FY2025
8-K
Current report, Q3 FY2025
Bridgebio Oncology Therapeutics, Inc. current report, Q3 FY2025
8-K
Quarterly report, Q2 FY2025
Bridgebio Oncology Therapeutics, Inc. quarterly report, Q2 FY2025
10-Q
Quarterly report, Q1 FY2025
Bridgebio Oncology Therapeutics, Inc. quarterly report, Q1 FY2025
10-Q